Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 132
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Curr Allergy Asthma Rep ; 23(6): 299-311, 2023 06.
Article in English | MEDLINE | ID: mdl-37166706

ABSTRACT

PURPOSE OF REVIEW: Burning of petroleum products has been consistently associated with adverse respiratory health effects. Combustion of crude oil, specifically, produces toxic byproducts, but there have been relatively few studies of health effects. Burning of crude oil is increasingly employed as a means of mitigating environmental disasters despite the potential health risks to workers involved in clean-up efforts. Here, we review epidemiological studies of respiratory effects following unique crude oil burning events to (1) characterize respiratory health effects from this nontraditional occupational exposure and (2) identify approaches used to characterize exposures that could be applied to future disaster-related studies. RECENT FINDINGS: We searched PubMed and EMBASE for references from inception to January 30, 2023. We also manually screened references cited in eligible articles. We identified 14 eligible publications. Our review suggests that exposure to crude oil combustion has adverse respiratory effects, including reduced lung function and increased occurrence of respiratory symptoms and disease. However, the evidence is inconsistent, and quality of data varied across studies. While some studies used quantitative, modeled exposure estimates, most used self-reported proxies of exposure. Although disasters involving crude oil combustion are relatively rare, limited evidence suggests that some worker populations may be at risk for respiratory effects from burning exposures in disaster settings. Future studies that use improved exposure assessment methods (e.g., personal monitors, remote sensing data) may help further quantify the respiratory risk from crude oil burning exposures.


Subject(s)
Disasters , Occupational Exposure , Petroleum Pollution , Petroleum , Respiration Disorders , Respiratory Tract Diseases , Humans , Petroleum/adverse effects , Petroleum Pollution/adverse effects , Occupational Exposure/adverse effects , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/etiology
2.
Nutrients ; 13(12)2021 Dec 14.
Article in English | MEDLINE | ID: mdl-34960012

ABSTRACT

Maternal iron deficiency occurs in 40-50% of all pregnancies and is associated with an increased risk of respiratory disease and asthma in children. We used murine models to examine the effects of lower iron status during pregnancy on lung function, inflammation and structure, as well as its contribution to increased severity of asthma in the offspring. A low iron diet during pregnancy impairs lung function, increases airway inflammation, and alters lung structure in the absence and presence of experimental asthma. A low iron diet during pregnancy further increases these major disease features in offspring with experimental asthma. Importantly, a low iron diet increases neutrophilic inflammation, which is indicative of more severe disease, in asthma. Together, our data demonstrate that lower dietary iron and systemic deficiency during pregnancy can lead to physiological, immunological and anatomical changes in the lungs and airways of offspring that predispose to greater susceptibility to respiratory disease. These findings suggest that correcting iron deficiency in pregnancy using iron supplements may play an important role in preventing or reducing the severity of respiratory disease in offspring. They also highlight the utility of experimental models for understanding how iron status in pregnancy affects disease outcomes in offspring and provide a means for testing the efficacy of different iron supplements for preventing disease.


Subject(s)
Iron Deficiencies/complications , Iron/administration & dosage , Respiratory Tract Diseases/etiology , Animals , Collagen/metabolism , Egg Proteins, Dietary , Female , Inflammation/etiology , Lung/growth & development , Lung/pathology , Maternal Nutritional Physiological Phenomena , Mice , Mice, Inbred BALB C , Pregnancy , Prenatal Exposure Delayed Effects , Prenatal Nutritional Physiological Phenomena
3.
Molecules ; 25(15)2020 Aug 04.
Article in English | MEDLINE | ID: mdl-32759721

ABSTRACT

Thyme (TO), cinnamon (CO), and Ceylon type lemongrass (LO) essential oils (EOs) are commonly used for inhalation. However, their effects and mechanisms on inflammatory processes are not well-documented, and the number of in vivo data that would be important to determine their potential benefits or risks is low. Therefore, we analyzed the chemical composition and investigated the activity of TO, CO, and LO on airway functions and inflammatory parameters in an acute pneumonitis mouse model. The components of commercially available EOs were measured by gas chromatography-mass spectrometry. Airway inflammation was induced by intratracheal endotoxin administration in mice. EOs were inhaled during the experiments. Airway function and hyperresponsiveness were determined by unrestrained whole-body plethysmography on conscious animals. Myeloperoxidase (MPO) activity was measured by spectrophotometry from lung tissue homogenates, from which semiquantitative histopathological scores were assessed. The main components of TO, CO, and LO were thymol, cinnamaldehyde, and citronellal, respectively. We provide here the first evidence that TO and CO reduce inflammatory airway hyperresponsiveness and certain cellular inflammatory parameters, so they can potentially be considered as adjuvant treatments in respiratory inflammatory conditions. In contrast, Ceylon type LO inhalation might have an irritant effect (e.g., increased airway hyperresponsiveness and MPO activity) on the inflamed airways, and therefore should be avoided.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Endotoxins/adverse effects , Oils, Volatile/pharmacology , Plant Oils/pharmacology , Thymus Plant/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Biomarkers , Disease Models, Animal , Female , Inflammation/drug therapy , Inflammation/etiology , Inflammation/pathology , Lung/drug effects , Lung/pathology , Mice , Oils, Volatile/chemistry , Plant Oils/chemistry , Respiratory Tract Diseases/drug therapy , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/pathology
4.
Ann Palliat Med ; 9(4): 1851-1858, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32576016

ABSTRACT

BACKGROUND: The application of factor analysis in the study of the clinical symptoms of coronavirus disease 2019 (COVID-19) was investigated, to provide a reference for basic research on COVID-19 and its prevention and control. METHODS: The data of 60 patients with COVID-19 in Jingzhou Hospital of Traditional Chinese Medicine and the Second People's Hospital of Longgang District in Shenzhen were extracted using principal component analysis. Factor analysis was used to investigate the factors related to symptoms of COVID-19. Based on the combination of factors, the clinical types of the factors were defined according to our professional knowledge. Factor loadings were calculated, and pairwise correlation analysis of symptoms was performed. RESULTS: Factor analysis showed that the clinical symptoms of COVID-19 cases could be divided into respiratory-digestive, neurological, cough-wheezing, upper respiratory, and digestive symptoms. Pairwise correlation analysis showed that there were a total of eight pairs of symptoms: fever-palpitation, coughexpectoration, expectoration-wheezing, dry mouth-bitter taste in the mouth, poor appetite-fatigue, fatiguedizziness, diarrhea-palpitation, and dizziness-headache. CONCLUSIONS: The symptoms and syndromes of COVID-19 are complex. Respiratory symptoms dominate, and digestive symptoms are also present. Factor analysis is suitable for studying the characteristics of the clinical symptoms of COVID-19, providing a new idea for the comprehensive analysis of clinical symptoms.


Subject(s)
Coronavirus Infections/complications , Pneumonia, Viral/complications , Adult , Aged , Aged, 80 and over , COVID-19 , Coronavirus Infections/therapy , Digestive System Diseases/etiology , Factor Analysis, Statistical , Female , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/therapy , Respiratory Tract Diseases/etiology , Young Adult
5.
Int J Epidemiol ; 49(1): 142-152, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31504557

ABSTRACT

BACKGROUND: Physical activity (PA) is beneficial to human health, whereas long-term exposure to air pollution is harmful. However, their combined effects remain unclear. We aimed to estimate the combined (interactive) mortality effects of PA and long-term exposure to fine particulate matter (PM2.5) among older adults in Hong Kong. METHODS: Participants aged ≥65 years from the Elderly Health Service Cohort (n = 66 820) reported their habitual PA at baseline (1998-2001) and were followed up till 31 December 2011. We used a satellite-based spatiotemporal model to estimate PM2.5 concentration at the residential address for each participant. We used Cox proportional hazards regression to assess the interaction between habitual PA and long-term exposure to PM2.5 on cardiovascular and respiratory mortality. We tested for additive interaction by estimating relative excess risk due to interaction and multiplicative interaction employing P-value for the interaction term. RESULTS: The death risks were inversely associated with a higher volume of PA and were positively associated with long-term exposure to PM2.5. The benefits of PA were more pronounced for participation in traditional Chinese exercise (e.g. Tai Chi) and aerobic exercise (e.g. cycling). We found little evidence of interaction between PA (volume and type) and long-term exposure to PM2.5 on either additive or multiplicative scales. CONCLUSIONS: In this cohort of older Chinese adults, PA may decrease the risk of mortality, be it in areas of relatively good or bad air quality. The beneficial mortality effects of habitual PA outweighed the detrimental effects of long-term exposure to air pollution in Hong Kong.


Subject(s)
Air Pollutants/adverse effects , Air Pollution/adverse effects , Asian People/statistics & numerical data , Cardiovascular Diseases/mortality , Environmental Exposure/adverse effects , Exercise , Particulate Matter/adverse effects , Respiratory Tract Diseases/mortality , Aged , Aged, 80 and over , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cohort Studies , Female , Humans , Male , Particulate Matter/analysis , Prospective Studies , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/etiology , Risk Assessment , Risk Factors
6.
Clin Transl Oncol ; 22(6): 852-859, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31392644

ABSTRACT

INTRODUCTION: In patients with peritoneal carcinomatosis (PC), the incidence of respiratory complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is not well established. We aimed to describe the center-specific incidence and patient characteristics associated with respiratory complications following CRS and HIPEC in patients receiving treatment for PC. MATERIALS AND METHODS: We used the University Hospital of Arrixaca study database to identify patients who underwent CRS and HIPEC for PC. Patients who experienced a post-operative respiratory complication were categorized according to the National Cancer Institute-Common Terminology Criteria for Adverse Events. Multivariable regression methods were used to identify independent risk factors for developing a respiratory complication following CRS and HIPEC. RESULTS: Between 2008 and 2017, we identified 247 patients who underwent CRS and HIPEC for PC. A total of eight patients (3.2%) were categorized as having a post-operative respiratory complication. A diaphragmatic peritonectomy and a PC index of > 14 were identified as independent risk factors for developing a respiratory complication. Radiographic evidence of a pleural effusion was identified in 72 patients who had CRS of the diaphragmatic peritoneum; however, only 6 (8.3%) of these patients required pleural drainage. CONCLUSIONS: Only 3.2% of patients developed a symptomatic respiratory complication following CRS and HIPEC. A pleural effusion was identified in almost all patients requiring a diaphragmatic peritonectomy as part of their CRS; however, less than one in ten of these patients required pleural drainage. Prophylactic insertion of a pleural drainage tube is, therefore, not indicated following CRS and HIPEC.


Subject(s)
Chemotherapy, Cancer, Regional Perfusion/adverse effects , Cytoreduction Surgical Procedures/adverse effects , Postoperative Complications/epidemiology , Respiratory Tract Diseases/epidemiology , Adult , Aged , Female , Humans , Hyperthermia, Induced/adverse effects , Incidence , Middle Aged , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/surgery , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/etiology
7.
Neumol. pediátr. (En línea) ; 14(3): 131-137, sept. 2019. tab
Article in Spanish | LILACS | ID: biblio-1087571

ABSTRACT

Chronic respiratory diseases compromise oxygenation to a variable degree and cause problems in the use of nutrients, the generation of energy and the use of it by different tissues and organs, with potential damage to respiratory function and non-respiratory systems. The available evidence indicates that both the available energy and some micronutrients, particularly with antioxidant activity, during pregnancy, are key for an adequate lung development and therefore an adequate pulmonary function in preterm infants, infants and older children, particularly if they attend bronchopulmonary dysplasia. However, both maternal and fetal malnutrition, as well as deficiencies of certain nutrients and the presence of overweight or obesity in the child, would influence the development of asthma in childhood. With regard to nutritional assistance, correction of nutritional deficit as well as micronutrients are essential in the treatment of diseases such as bronchopulmonary dysplasia, bronchiolitis obliterans and asthma. This review aims to establish how nutrition determines the development, evolution and prognosis of these pathologies and the need to consider nutritional assistance in the comprehensive care of these patients.


Las enfermedades respiratorias crónicas comprometen la oxigenación en grado variable y ocasionan problemas en el uso de los nutrientes, la generación de energía y la utilización de ésta por los distintos tejidos y órganos, con potencial daño en la función respiratoria y en los sistemas no respiratorios. La evidencia disponible señala que tanto la energía disponible y algunos micronutrientes, particularmente con actividad antioxidante, durante la gestación, son claves para un adecuado desarrollo pulmonar y por lo tanto una adecuada función pulmonar en prematuros, lactantes y niños mayores, en particular si cursan con displasia broncopulmonar. Sin embargo tanto la desnutrición materna y fetal, como las deficiencias de ciertos nutrientes y la presencia de sobrepeso u obesidad en el niño, influirían en el desarrollo de asma en la infancia. En lo referente a la asistencia nutricional, la corrección del déficit nutricional así como de micronutrientes, es indispensable en el tratamiento de enfermedades como la displasia broncopulmonar, la bronquiolitis obliterante y el asma. Esta revisión pretende establecer cómo la nutrición determina el desarrollo, evolución y pronóstico de estas patologías y la necesidad de considerar la asistencia nutricional en la atención integral de estos pacientes.


Subject(s)
Humans , Child , Respiratory Tract Diseases/etiology , Nutritional Physiological Phenomena , Respiratory Tract Diseases/diet therapy , Chronic Disease
8.
Rev Chil Pediatr ; 90(1): 94-101, 2019.
Article in Spanish | MEDLINE | ID: mdl-31095224

ABSTRACT

The better understanding of the global activity of vitamin D has led to an intense search for its involvement in non-skeletal diseases. This article presents an updated review of the relationship between vitamin D and pediatric respiratory pathology. A literature search was performed in PUBMED using free terms and MESH terms: vitamin D, asthma, respiratory system diseases, and bronchiolitis. Stu dies in human patients younger than 18 years and animals, published in English and Spanish until 2017 were included. 507 articles were found, of which 43 were included. Indirect evidence suggests a role of vitamin D and fetal lung maturation. In relation to pediatric pulmonary pathology, studies are scarce and inconclusive. Recent meta-analyses performed with individualized evaluation of the participants shows an important protective role of vitamin D supplementation in the prevention of severe asthma exacerbations and acute viral infections. In bronchiolitis, the results are contradictory, with no clear relationship between plasma levels and severity. There is not enough evidence to assess the benefits of vitamin D supplementation in cystic fibrosis and tuberculosis. A direct relationship between the severity of sleep-related breathing disorders and vitamin D plasma levels has recently been proposed, although the exact mechanisms involved in this association are unknown. Current information suggests that vitamin D supplementation may represent a cost-effective strategy in redu cing important causes of infant morbidity and mortality.


Subject(s)
Respiratory Tract Diseases/etiology , Vitamin D Deficiency/complications , Biomarkers/blood , Child , Dietary Supplements , Humans , Lung/embryology , Pediatrics , Respiratory Tract Diseases/drug therapy , Respiratory Tract Diseases/prevention & control , Risk Factors , Vitamin D/blood , Vitamin D/physiology , Vitamin D/therapeutic use , Vitamin D Deficiency/blood , Vitamin D Deficiency/diagnosis , Vitamin D Deficiency/drug therapy , Vitamins/blood , Vitamins/physiology , Vitamins/therapeutic use
9.
J Occup Environ Med ; 61(7): 565-571, 2019 07.
Article in English | MEDLINE | ID: mdl-31045853

ABSTRACT

OBJECTIVE: The aim of this study was to assess chronic respiratory symptoms and lung function among female hand pickers. METHODS: A total of 374 hand pickers exposed to coffee dust and 175 female controls from water bottling factories were included. The symptoms were assessed using a standardized questionnaire. Personal total dust exposure and lung function tests were performed. RESULTS: Hand pickers experienced a higher dust exposure, displayed a higher prevalence ratio for cough [prevalence ratio (PR) = 3.0, 95% confidence interval (95% CI): 1.4 to 6.2] and work-related shortness of breath (PR = 2.5, 95% CI: 1.1 to 5.6), and had a lower FEF25-75 than controls. Hand pickers without tables had a significantly higher prevalence ratio of cough with sputum (PR = 3.9, 95% CI: 1.6 to 9.5) and lower forced vital capacity, forced expiratory volume in 1 second, and mean forced expiratory flow between 25% and 75% of the FVC than hand pickers with tables. CONCLUSION: Hand pickers show a range of adverse symptoms and lung function impairments that warrant efforts to improve working conditions.


Subject(s)
Coffee , Food-Processing Industry , Manufacturing and Industrial Facilities , Occupational Diseases/epidemiology , Respiratory Tract Diseases/epidemiology , Adolescent , Adult , Air Pollutants, Occupational/analysis , Air Pollutants, Occupational/toxicity , Case-Control Studies , Chronic Disease , Cross-Sectional Studies , Dust/analysis , Ethiopia/epidemiology , Female , Humans , Middle Aged , Occupational Diseases/diagnosis , Occupational Diseases/etiology , Occupational Exposure/adverse effects , Occupational Exposure/analysis , Respiratory Function Tests , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/etiology , Young Adult
10.
J Pediatr Surg ; 54(2): 251-254, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30503023

ABSTRACT

OBJECTIVE: The objective of this study was to report our multidisciplinary diagnostic approach for patients with anterior mediastinal masses (AMM). METHODS: A retrospective review of patients with AMM at a tertiary pediatric surgical oncology centre (January 2011-December 2016) was performed. We analyzed data on clinical presentation, mode of tissue diagnosis, anesthetic techniques, and complications. RESULTS: Of the 44 patients admitted with AMM (median age 11 years, 27 males and 17 females), 22 had respiratory symptoms. Imaging revealed tracheobronchial compression in 26 children. Twenty patients had a lymph node biopsy. Ten patients had image-guided core biopsy of the mediastinal mass, and 2 had mediastinoscopic biopsy of a paratracheal lymph node. One patient with likely recurrence of a relapsed metastatic ethmoid carcinoma did not have a biopsy. The diagnosis was made from alternative tissues, such as pleural fluid in 4 and peripheral blood in 7 patients. Twenty-five anesthetics were assessed, as 14 patients required no or only local anesthesia, and 5 had unavailable anesthetic notes. Eighteen of 25 patients were anesthetized maintaining spontaneous breathing, mostly by means of ketamine sedation. There were no major anesthetic complications. CONCLUSION: Safe tissue diagnosis of anterior mediastinal masses can be obtained by a personalized multidisciplinary approach. Use of alternative tissues, local anesthesia, and ketamine sedation help minimize the need for general anesthesia, muscle paralysis, and controlled ventilation. LEVEL OF EVIDENCE: IV (Case Series with no Comparison Group).


Subject(s)
Lymph Nodes/pathology , Mediastinal Neoplasms/diagnosis , Mediastinal Neoplasms/pathology , Adolescent , Anesthesia, General , Anesthesia, Local , Anesthetics, Dissociative , Child , Child, Preschool , Female , Humans , Image-Guided Biopsy , Ketamine , Male , Mediastinal Neoplasms/complications , Mediastinoscopy , Patient Care Team , Pleural Effusion/etiology , Respiratory Tract Diseases/etiology , Retrospective Studies
11.
Allergy Asthma Proc ; 40(1): 4-6, 2019 Jan 01.
Article in English | MEDLINE | ID: mdl-30582489

ABSTRACT

Background: Aspirin-exacerbated respiratory disease (AERD), a syndrome that includes asthma, recurrent nasal polyps, and pathognomonic reactions to aspirin and other nonselective cyclooxygenase inhibitors, is still not fully understood and lacks specific disease-modifying therapeutic options. Objective: To review the most recent clinical updates in the evaluation and treatment of patients with AERD. Methods: Recent clinical research studies relevant to patients with AERD were reviewed. Results: Multiple new biologics are available for the treatment of severe asthma, several of which have been specifically studied and determined to be efficacious in the subset of patients with asthma who are also aspirin sensitive. Zileuton continues to be underprescribed for AERD and is considered to be very effective by many patients with AERD. Dietary modifications toward a diet that is high in omega-3 fatty acids and low in omega-6 fatty acids can reduce the production of the inflammatory leukotriene and prostaglandin D2 lipids and help improve symptoms for patients with AERD. Conclusion: A lack of definitive understanding of the causative mechanisms of AERD and the absence of an AERD-specific patient-reported outcome measure are obstacles that remain in this field, but much progress has been made over the past decade.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/therapy , Asthma, Aspirin-Induced , Disease Management , Health Services Needs and Demand , Humans , Patient Care , Syndrome
12.
Rev. chil. pediatr ; 90(1): 94-101, 2019. tab
Article in Spanish | LILACS | ID: biblio-990891

ABSTRACT

Resumen: El mejor entendimiento sobre la actividad global de la vitamina D, ha llevado a una intensa búsque da de sus implicancias en enfermedades no esqueléticas. En este artículo se presenta una revisión actualizada de la relación entre la vitamina D y la patología respiratoria pediátrica. Se realizó una búsqueda bibliográfica en PUBMED utilizando términos libres y MESH: vitamina D, enfermedades del sistema respiratorio, asma, bronquiolitis. Se seleccionó estudios en humanos menores de 18 años y animales, publicados en inglés y español hasta el 2017. Se encontraron 507 artículos, de los cuales se incluyeron 43. Evidencia indirecta apunta hacia un rol de la vitamina D y la maduración pulmonar fetal. En relación a la patología pulmonar pediátrica, los estudios son escasos y poco concluyentes. Nuevos meta - análisis, con evaluación individualizada de los participantes, muestran un importante rol protector de la suplementación en la prevención de exacerbaciones asmáticas severas e infecciones virales agudas. En bronquiolitis los resultados son contradictorios, sin relación clara entre niveles plasmáticos y severidad. No existe suficiente evidencia que evalué los beneficios en fibrosis quística y tuberculosis. Recientemente se ha propuesto una relación directa entre la severidad de los trastornos respiratorios del sueño y los niveles plasmáticos de vitamina D, aunque se desconoce los mecanismos exactos involucrados a esta asociación. La información actual permite suponer que la suplementación de vitamina D puede representar una estrategia costo - efectiva en la reducción de importantes causas de morbimortalidad infantil.


Abstract: The better understanding of the global activity of vitamin D has led to an intense search for its involvement in non-skeletal diseases. This article presents an updated review of the relationship between vitamin D and pediatric respiratory pathology. A literature search was performed in PUBMED using free terms and MESH terms: vitamin D, asthma, respiratory system diseases, and bronchiolitis. Stu dies in human patients younger than 18 years and animals, published in English and Spanish until 2017 were included. 507 articles were found, of which 43 were included. Indirect evidence suggests a role of vitamin D and fetal lung maturation. In relation to pediatric pulmonary pathology, studies are scarce and inconclusive. Recent meta-analyses performed with individualized evaluation of the participants shows an important protective role of vitamin D supplementation in the prevention of severe asthma exacerbations and acute viral infections. In bronchiolitis, the results are contradictory, with no clear relationship between plasma levels and severity. There is not enough evidence to assess the benefits of vitamin D supplementation in cystic fibrosis and tuberculosis. A direct relationship between the severity of sleep-related breathing disorders and vitamin D plasma levels has recently been proposed, although the exact mechanisms involved in this association are unknown. Current information suggests that vitamin D supplementation may represent a cost-effective strategy in redu cing important causes of infant morbidity and mortality.


Subject(s)
Humans , Child , Respiratory Tract Diseases/etiology , Vitamin D Deficiency/complications , Pediatrics , Respiratory Tract Diseases/prevention & control , Respiratory Tract Diseases/drug therapy , Vitamin D/physiology , Vitamin D/blood , Vitamin D/therapeutic use , Vitamin D Deficiency/diagnosis , Vitamin D Deficiency/drug therapy , Vitamin D Deficiency/blood , Vitamins/physiology , Vitamins/blood , Vitamins/therapeutic use , Biomarkers/blood , Risk Factors , Dietary Supplements , Lung/embryology
13.
Trials ; 19(1): 669, 2018 Dec 04.
Article in English | MEDLINE | ID: mdl-30514358

ABSTRACT

BACKGROUND: Transcutaneous electric acupoint stimulation (TEAS) has shown benefits when used peri-operatively. However, the role of numbers of areas with acupoint stimulation is still unclear. Therefore, we report the protocol of a randomized controlled trial of using TEAS in elderly patients subjected to gastrointestinal surgery, and comparing dual-acupoint and single-acupoint stimulation. METHODS/DESIGN: A multicenter, randomized, controlled, three-arm design, large-scale trial is currently undergoing in four hospitals in China. Three hundred and forty-five participants are randomly assigned to three groups in a 1:1:1 ratio, receiving dual-acupoint TEAS, single-acupoint TEAS, and no stimulation, respectively. The primary outcome is incidence of pulmonary complications at 30 days after surgery. The secondary outcomes include the incidence of pulmonary complications at 3 days after surgery; the all-cause mortality within 30 days and 1 year after surgery; admission to the intensive care unit (ICU) and length of ICU stay within 30 days after surgery; the length of postoperative hospital stay; and medical costs during hospitalization after surgery. DISCUSSION: The result of this trial (which will be available in September 2019) will confirm whether TEAS before and during anesthesia could alleviate the postoperative pulmonary complications after gastrointestinal surgery in elderly patients, and whether dual-acupoint stimulation is more effective than single-acupoint stimulation. TRIALS REGISTRATIONS: ClinicalTrials.gov, ID: NCT03230045 . Registered on 10 July 2017.


Subject(s)
Acupuncture Points , Digestive System Surgical Procedures , Electroacupuncture/methods , Gastrointestinal Tract/surgery , Respiratory Tract Diseases/prevention & control , Age Factors , Aged , China , Digestive System Surgical Procedures/adverse effects , Digestive System Surgical Procedures/economics , Digestive System Surgical Procedures/mortality , Electroacupuncture/adverse effects , Electroacupuncture/economics , Electroacupuncture/mortality , Female , Health Care Costs , Humans , Intensive Care Units , Length of Stay , Male , Multicenter Studies as Topic , Randomized Controlled Trials as Topic , Respiratory Tract Diseases/economics , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/mortality , Risk Factors , Time Factors , Treatment Outcome
14.
Nutrients ; 10(7)2018 Jul 18.
Article in English | MEDLINE | ID: mdl-30021997

ABSTRACT

Experimental evidence from animal models and epidemiology studies has demonstrated that nutrition affects lung development and may have a lifelong impact on respiratory health. Chronic restriction of nutrients and/or oxygen during pregnancy causes structural changes in the airways and parenchyma that may result in abnormal lung function, which is tracked throughout life. Inadequate nutritional management in very premature infants hampers lung growth and may be a contributing factor in the pathogenesis of bronchopulmonary dysplasia. Recent evidence seems to indicate that infant and childhood malnutrition does not determine lung function impairment even in the presence of reduced lung size due to delayed body growth. This review will focus on the effects of malnutrition occurring at critical time periods such as pregnancy, early life, and childhood, on lung growth and long-term lung function.


Subject(s)
Diet, Healthy , Evidence-Based Medicine , Health Status , Lung/growth & development , Nutritional Status , Respiratory Tract Diseases/prevention & control , Adult , Animals , Bronchopulmonary Dysplasia/etiology , Bronchopulmonary Dysplasia/physiopathology , Bronchopulmonary Dysplasia/prevention & control , Child , Child Nutritional Physiological Phenomena , Female , Fetal Growth Retardation/etiology , Fetal Growth Retardation/physiopathology , Fetal Growth Retardation/prevention & control , Humans , Infant, Newborn , Lung/embryology , Lung/physiology , Lung/physiopathology , Malnutrition/physiopathology , Malnutrition/prevention & control , Maternal Nutritional Physiological Phenomena , Pregnancy , Pregnancy Complications/physiopathology , Pregnancy Complications/prevention & control , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/physiopathology
15.
J Vasc Surg ; 68(4): 1023-1029.e2, 2018 10.
Article in English | MEDLINE | ID: mdl-29602472

ABSTRACT

OBJECTIVE: Percutaneous endovascular aneurysm repair (EVAR) can be performed with general anesthesia (GA) or local anesthesia (LA). Our goal was to assess perioperative outcomes comparing anesthesia type in percutaneous EVAR. METHODS: The Vascular Quality Initiative database was queried for all exclusively percutaneous EVAR procedures. Univariable analysis was used to compare which patients were offered LA. Multivariable analysis was used to determine the independent effect of anesthesia type. RESULTS: There were 8141 percutaneous EVARs identified in the Vascular Quality Initiative database. Average age was 73 years, and 83% were male. GA and LA were used in 7387 (90.7%) and 754 (9.3%) cases, respectively. GA was used more often in patients who were younger (72.8 ± 8 vs 74.3 ± 9), white (89% vs 84.5%), and on Medicare (62% vs 61.5%); in patients with higher body mass index (28.3 ± 6 vs 27.3 ± 7), hypertension (81.5% vs 77.8%), diabetes (20.5% vs 17.4%), and previous lower extremity bypass (1.7% vs 0.5%); and in patients undergoing elective repair (86.4% vs 81.3%). Use of GA was associated with lower rates of preoperative congestive heart failure (11.6% vs 16.1%), preoperative anticoagulation (11.7% vs 14.2%), and less use of ultrasound guidance (81.5% vs 88.8%; P < .05). There was no difference in patients with chronic obstructive pulmonary disease, coronary artery disease, previous aneurysm repair, and concomitant iliac aneurysm repair. Multivariable analysis showed that GA compared with LA was associated with more pulmonary complications (odds ratio, 2.8; 95% confidence interval, 1.49-5.43; P = .002) and prolonged operative time (means ratio, 1.11; 95% confidence interval, 1.08-1.52; P < .001). There was no independent effect on overall complications, cardiac complications, or mortality. CONCLUSIONS: Although it was used in only 1 in 10 cases of percutaneous EVAR, LA was associated with fewer pulmonary complications after adjustment for patient factors. Surgeons should consider expanding the use of LA for percutaneous EVAR when feasible.


Subject(s)
Anesthesia, General , Anesthesia, Local , Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/methods , Endovascular Procedures/methods , Respiratory Tract Diseases/etiology , Age Factors , Aged , Aged, 80 and over , Anesthesia, General/adverse effects , Anesthesia, General/mortality , Anesthesia, Local/adverse effects , Anesthesia, Local/mortality , Aortic Aneurysm, Abdominal/mortality , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Chi-Square Distribution , Comorbidity , Databases, Factual , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Health Status , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Propensity Score , Respiratory Tract Diseases/mortality , Retrospective Studies , Risk Factors , Treatment Outcome
16.
J Pediatr ; 191: 57-62.e2, 2017 12.
Article in English | MEDLINE | ID: mdl-29173323

ABSTRACT

OBJECTIVE: To assess the relationship between breastfeeding initiation time and postneonatal mortality, morbidity, and growth through 24 months in a cohort of Tanzanian infants. STUDY DESIGN: We included 4203 infants from 2 trials of micronutrient supplementation. We used Cox proportional hazards models or general estimating equations to estimate relative risks. RESULTS: A total of 13% of infants initiated breastfeeding >1 hour after birth (n = 536). There was no association between breastfeeding initiation time and risk of all-cause or cause-specific mortality, nor infant growth failure, from 6 weeks to 2 years of age. However, delayed breastfeeding was associated with an increased risk of several common infectious morbidities in early infancy, including upper respiratory infection symptoms and vomiting. Compared with those who initiated breastfeeding within the first hour of birth, delayed breastfeeding initiation was associated with an 11% increased risk of cough (relative risk 1.11, 95% CI 1.02-1.21) and a 48% increased risk of difficulty breathing (relative risk 1.48, 95% CI 1.09-2.01) during the first 6 months. Delayed initiation was associated with a greater risk of difficulty breathing from 6 to 12 months of age, but it was not associated with risk of any other morbidity during this time, nor any morbidity between 12 and 24 months. CONCLUSION: Delayed breastfeeding initiation is associated with an increased risk of infant morbidity during the first 6 months of life. Early breastfeeding initiation, along with exclusive and prolonged breastfeeding, should be prioritized and promoted in efforts to improve child health.


Subject(s)
Breast Feeding/statistics & numerical data , Growth Disorders/etiology , Infections/etiology , Respiratory Tract Diseases/etiology , Age Factors , Child Development , Child, Preschool , Female , Growth Disorders/epidemiology , Growth Disorders/prevention & control , Humans , Infant , Infant, Newborn , Infections/epidemiology , Longitudinal Studies , Male , Proportional Hazards Models , Prospective Studies , Protective Factors , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/prevention & control , Risk Factors , Tanzania/epidemiology , Time Factors
17.
Int J Mol Med ; 40(5): 1557-1565, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28949372

ABSTRACT

Physalis peruviana L. (PP) is a medicinal herb that has been confirmed to have several biological activities, including anticancer, antioxidant and anti-inflammatory properties. The aim of the present study was to evaluate the protective effect of PP on cigarette smoke (CS)- and lipopolysaccharide (LPS)-induced pulmonary inflammation. Treatment with PP significantly reduced the influx of inflammatory cells in the bronchoalveolar lavage fluid (BALF) and lung of mice with CS- and LPS-induced pulmonary inflammation. PP also decreased the levels of reactive oxygen species (ROS) and pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the BALF. PP effectively attenuated the expression of monocyte chemoattractant protein-1 (MCP-1) and the activation of extracellular signal-regulated kinase (ERK) in the lung. In addition, nuclear factor erythroid 2-related factor 2 (Nrf2) activation and heme oxygenase-1 (HO-1) expression were increased by PP treatment. In an in vitro experiment, PP reduced the mRNA expression of TNF-α and MCP-1, and the activation of ERK in CS extract-stimulated A549 epithelial cells. Furthermore, PP increased the activation of Nrf2 and the expression of HO-1 in A549 cells. These findings suggest that PP has a therapeutic potential for the treatment of pulmonary inflammatory diseases, such as chronic obstructive pulmonary disease.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , Heme Oxygenase-1/metabolism , Inflammation/etiology , Inflammation/metabolism , Lipopolysaccharides/adverse effects , Physalis/chemistry , Plant Extracts/pharmacology , Smoking/adverse effects , Animals , Biomarkers , Bronchoalveolar Lavage Fluid/cytology , Cell Line, Tumor , Chemokine CCL2/metabolism , Cytokines/metabolism , Disease Models, Animal , Gene Expression Regulation , Heme Oxygenase-1/genetics , Humans , Inflammation/pathology , Inflammation Mediators , Leukocytes/metabolism , Leukocytes/pathology , Male , Mice , Neutrophil Infiltration , Neutrophils/metabolism , Neutrophils/pathology , Plant Extracts/chemistry , Reactive Oxygen Species , Respiratory Mucosa/metabolism , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/metabolism , Respiratory Tract Diseases/pathology
18.
Am Fam Physician ; 95(9): 554-560, 2017 May 01.
Article in English | MEDLINE | ID: mdl-28671392

ABSTRACT

Illness after recreational water activities can be caused by a variety of agents, including bacteria, viruses, parasites, algae, and even chlorine gas. These illnesses are more common in summer. Waterborne illnesses are underreported because most recreational activity occurs in unsupervised venues or on private property, and participants tend to disperse before illness occurs. Symptoms of waterborne illness are primarily gastrointestinal, but upper respiratory and skin manifestations also occur. Gastrointestinal symptoms are usually self-limited, and supportive treatment may be all that is necessary. However, some infections can cause significant morbidity and mortality. Cryptosporidium and Giardia intestinalis are the most common cause of gastrointestinal illness and have partial chlorine resistance. Respiratory infections are typically mild and self-limited. However, if legionnaires' disease develops and is unrecognized, mortality may be as high as 10%. Cellulitis caused by Vibrio vulnificus can result in serious illness, amputation, and death. Early and appropriate antibiotic treatment is important. Chronically ill and immunocompromised persons are at high risk of infection and should be counseled accordingly.


Subject(s)
Waterborne Diseases/diagnosis , Gastrointestinal Diseases/etiology , Gastrointestinal Diseases/microbiology , Gastrointestinal Diseases/parasitology , Humans , Leptospirosis/etiology , Recreation , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/microbiology , Skin Diseases/etiology , Skin Diseases/microbiology , Waterborne Diseases/prevention & control , Waterborne Diseases/therapy
19.
Paediatr Respir Rev ; 21: 27-33, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27639458

ABSTRACT

Maternal smoking during pregnancy is the largest preventable cause of abnormal in-utero lung development. Despite well known risks, rates of smoking during pregnancy have only slightly decreased over the last ten years, with rates varying from 5-40% worldwide resulting in tens of millions of fetal exposures. Despite multiple approaches to smoking cessation about 50% of smokers will continue to smoke during pregnancy. Maternal genotype plays an important role in the likelihood of continued smoking during pregnancy and the degree to which maternal smoking will affect the fetus. The primary effects of maternal smoking on offspring lung function and health are decreases in forced expiratory flows, decreased passive respiratory compliance, increased hospitalization for respiratory infections, and an increased prevalence of childhood wheeze and asthma. Nicotine appears to be the responsible component of tobacco smoke that affects lung development, and some of the effects of maternal smoking on lung development can be prevented by supplemental vitamin C. Because nicotine is the key agent for affecting lung development, e-cigarette usage during pregnancy is likely to be as dangerous to fetal lung development as is maternal smoking.


Subject(s)
Lung/embryology , Prenatal Exposure Delayed Effects/epidemiology , Respiratory Tract Diseases/epidemiology , Smoking/epidemiology , Tobacco Smoke Pollution/statistics & numerical data , Animals , Antioxidants/therapeutic use , Ascorbic Acid/therapeutic use , Asthma/epidemiology , Asthma/etiology , Asthma/genetics , Asthma/prevention & control , Child , Disease Models, Animal , Epigenesis, Genetic , Female , Humans , Infant, Newborn , Lung/drug effects , Lung/growth & development , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/prevention & control , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/genetics , Respiratory Tract Diseases/prevention & control , Smoking/adverse effects , Tobacco Smoke Pollution/adverse effects
20.
J Bodyw Mov Ther ; 20(4): 704-714, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27814848

ABSTRACT

Respiratory function of patients with neck pain has not been given much consideration in usual clinical practice. The problem has however been highlighted occasionally by renown clinical scientists and recently there is a growing interest in the investigation of respiratory function in this clinical population. The aim of this review is to critically present the emerging evidence and discuss the similarities and differences observed. Although the evidence for some respiratory parameters is conflicting, it seems to be generally agreed that others such as maximal voluntary ventilation, strength of respiratory muscles, chest mechanics and partial pressure of arterial carbon dioxide are affected in patients with chronic neck pain. The effect size of the respiratory dysfunction regarding these respiratory parameters can be approximately described as moderate. These findings not only suggest a more thoughtful drug prescription, but they may lead to consideration of incorporation of respiratory assessment and treatment into routine physiotherapy practice. Indeed preliminary studies exploring the incorporation of such a treatment into usual practice have provided very promising results not only in relation to respiratory function, but also for other parameters of clinical interest. There remains however imminent need for randomized controlled trials to confirm the evidence base for such an approach.


Subject(s)
Neck Pain/complications , Neck Pain/physiopathology , Respiration , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/physiopathology , Biomechanical Phenomena , Carbon Dioxide/blood , Cervical Vertebrae/physiopathology , Chronic Pain , Humans , Musculoskeletal Manipulations , Posture/physiology , Respiratory Function Tests , Respiratory Muscles/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL